Share on facebook
Share on pinterest
Share on twitter
Share on email
Share on whatsapp

Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice

Inflammopharmacology 2018

Ruth Gallily1, Zhannah Yekhtin1

1The Lautenberg Center for General and Tumor Immunology, The Hadassah Medical School, The Hebrew University of Jerusalem, Jerusalem, Israel

Multiple sclerosis is an autoimmune disease that affects the central nervous system. The disease can be treated with immunosuppressive drugs that alleviate the symptoms and retard disease aggravation. An example of such a drug is Copaxone, an immunosuppressive medication that is used to alleviate the symptoms of multiple sclerosis. Recently, it has been shown that the cannabidiol component in the cannabis plant has a positive effect on the model of multiple sclerosis in animals, an acute, inflammatory disease that attacks the myelin sheath. The aim of this study, conducted in collaboration with the Hebrew University, was to compare the efficacy of purified CBD, extracts of CBD-rich Avidekel, and Copaxone.

STUDY POPULATION: Lab mice.

STUDY PRODUCT: Avidekel.

RESULTS:

  • Avidekel may be useful in the treatment of multiple sclerosis symptoms.
  • Avidekel strain extracts and cannabidiol are as efficient as COPAXONE® in immunosuppression in-vivo laboratory experiment examined the effect of multiple sclerosis symptoms in mice.
  • Both CBD and Avidekel extracts efficiently inhibited the clinical symptoms appearing during all the study phases.

FULL STUDY

Have you liked our facebook page?

Common Questions

Ordering Tikun Olam Products

Proudly leading the revolution for modern Cannabis treatment

Related Topics

SAFETY AND EFFICACY OF MEDICAL CANNABIS IN FIBROMYALGIA Journal of Clinical Medicine, 2019 Iftach Sagy MD PhD1,2, Lihi Bar-Lev Schleider MA2,3, Mahmoud Abu-Shakra MD4 and

Over the years we have invested in clinical research and collected very extensive knowledge and experience in the field of medical cannabis treatments for children,

Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities Frontiers in Pharmacology, 2019 Dana Barchel1, Orit Stolar2, Tal De-Haan1,

Prospective Analysis of Safety and Efficacy of Medical Cannabis in Large Unselected Population of Patients with Cancer European Journal of Internal Medicine, 2018 Lihi Bar-Lev

whatsapp

תודה על הגשת מועמדותך, במידה וקורות החיים ימצאו רלוונטיים ניצור קשר. בהצלחה!